Although no published data are available in AD mouse models, in the P301S tauopathy mouse model, edicotinib significantly inhibited microglial proliferation, tau phosphorylation, neurodegeneration, and normalized the gene expression profile of microglia (Mancuso et al., 2019). Here, MAPT is linked to Alzheimer disease.